Upregulated programmed cell death ligand 1 (PD-L1) in glioma cells can block T cell activation and stimulate T cell apoptosis by binding to programmed death ligand 1 (PD-1), a suppressive immune checkpoint (17, 18). This evidence concerns the gene PDCD1 and central nervous system cancer.